Risk factors for discordant immune response among HIV-infected patients initiating antiretroviral therapy: A retrospective cohort study

• Hauptverfasser: B P Muzah (Verfasst von), S Takuva (Verfasst von), M Maskew (Verfasst von), S Delany-Moretlwe (Verfasst von)
• Format: Buch
• Veröffentlicht: AOSIS, 2012-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background. The therapeutic goal of antiretroviral therapy (ART) is sustained immune recovery and viral suppression. However, some patients experience poor CD4 cell count responses despite achieving viral suppression. Such discordant immune responses have been associated with poor clinical outcomes....